Sale!

TNFSF11 Gene Osteopetrosis Autosomal Recessive Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TNFSF11 Gene Osteopetrosis Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic tool used to identify mutations in the TNFSF11 gene, which are responsible for causing Osteopetrosis Autosomal Recessive Type 2 (OPTA2). This condition is a rare genetic disorder characterized by increased bone density and abnormal bone growth, leading to a range of complications such as bone fragility, abnormal posture, and in severe cases, neurological issues due to nerve compression.

The test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. By analyzing a patient’s DNA sample, usually obtained through a blood draw, the test can pinpoint specific genetic alterations in the TNFSF11 gene that are indicative of OPTA2. This information is crucial for confirming the diagnosis, understanding the disease’s progression, and tailoring a treatment plan that addresses the patient’s specific needs.

The cost of the TNFSF11 Gene Osteopetrosis Autosomal Recessive Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, from the initial DNA extraction to the detailed analysis and reporting of results. Given the complexity of OPTA2 and the importance of early and accurate diagnosis in managing the condition, this test represents a valuable investment in a patient’s health and well-being.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TNFSF11 Gene Osteopetrosis Autosomal Recessive Type 2 Genetic Test

At DNA Labs UAE, we offer the TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test. This test is designed to analyze the TNFSF11 gene for mutations associated with autosomal recessive type 2 osteopetrosis. Osteopetrosis is a rare genetic disorder characterized by increased bone density and abnormal bone growth.

Test Components and Price

The TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery

The report for the TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test is typically delivered within 3 to 4 weeks.

Method and Test Type

The TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze the TNFSF11 gene for mutations. This test falls under the categories of Osteology, Dermatology, and Immunology Disorders.

Doctor and Test Department

The TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test is performed by a Dermatologist in the Genetics department.

Pre Test Information

Prior to undergoing the TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test, it is recommended to provide the clinical history of the patient. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with TNFSF11 Gene Osteopetrosis, autosomal recessive type 2 NGS Genetic DNA Test gene TNFSF11.

Test Details

The TNFSF11 gene osteopetrosis, autosomal recessive type 2 NGS genetic test is a genetic test that analyzes the TNFSF11 gene for mutations associated with autosomal recessive type 2 osteopetrosis. The TNFSF11 gene is responsible for producing a protein called RANK ligand, which is involved in the regulation of bone remodeling and the differentiation and activation of osteoclasts.

The NGS genetic test for TNFSF11 gene osteopetrosis analyzes the entire coding region of the TNFSF11 gene to identify any mutations or genetic variants that may be associated with the condition. This test can help confirm a diagnosis of autosomal recessive type 2 osteopetrosis and provide information about the specific genetic variant(s) present in an individual.

The results of the test can be used to guide treatment decisions and management strategies for individuals with osteopetrosis. They can also provide information about the risk of passing on the condition to future generations and help with genetic counseling and family planning.

It is important to note that genetic testing for TNFSF11 gene osteopetrosis should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name TNFSF11 Gene Osteopetrosis autosomal recessive type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TNFSF11 Gene Osteopetrosis, autosomal recessive type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TNFSF11 Gene Osteopetrosis, autosomal recessive type 2 NGS Genetic DNA Test gene TNFSF11
Test Details

TNFSF11 gene osteopetrosis, autosomal recessive type 2 NGS genetic test is a genetic test that uses Next-Generation Sequencing (NGS) technology to analyze the TNFSF11 gene for mutations associated with autosomal recessive type 2 osteopetrosis.

Osteopetrosis is a rare genetic disorder characterized by increased bone density and abnormal bone growth. Autosomal recessive type 2 osteopetrosis is caused by mutations in the TNFSF11 gene, which is responsible for producing a protein called RANK ligand. This protein is involved in the regulation of bone remodeling and the differentiation and activation of osteoclasts, which are cells responsible for breaking down and resorbing bone tissue.

The NGS genetic test for TNFSF11 gene osteopetrosis analyzes the entire coding region of the TNFSF11 gene to identify any mutations or genetic variants that may be associated with the condition. This test can help confirm a diagnosis of autosomal recessive type 2 osteopetrosis and provide information about the specific genetic variant(s) present in an individual.

The results of the test can be used to guide treatment decisions and management strategies for individuals with osteopetrosis. They can also provide information about the risk of passing on the condition to future generations and help with genetic counseling and family planning.

It is important to note that genetic testing for TNFSF11 gene osteopetrosis should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.